National Cancer Institute

at the National Institutes of Health

A retrospective analysis of more than 36,000 patients with colon cancer showed that those with early stage disease and diabetes or high blood pressure -- two components of metabolic syndrome -- have a greater risk for cancer recurrence and of dying compared to patients without either condition. The results suggest such patients may need to be followed more closely and could potentially benefit from wider use of additional chemotherapy.

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.